RICHMOND, VA--(Marketwire - January 22, 2013) - ALR Technologies Inc. (OTCBB: ALRT), a medical device company providing remote monitoring and care facilitation for patients with chronic diseases, today released a video demonstrating how the ALRT's Diabetes Care Facilitators (DCFs) use the Health-e-Connect System. DCFs monitor patient blood glucose data, testing and care plan adherence as well as facilitate care using a robust communications platform to connect patients, providers, caregivers and health plans. For information regarding the effectiveness of the program, please refer to: http://www.youtube.com/watch?v=vo6Bca8vjh4
Finally, the video also explains how the Health-e-Connect system is designed so DCFs can monitor patient activities that are important for health plans to achieve optimal NCQA HEDIS scores.
Sidney Chan, ALRT CEO, said, "Our Health-e-Connect system is a unique product because it represents an inexpensive and effective way to facilitate patient care anchored on verifiable data."
ALRT President Larry Weinstein added, "Remote monitoring technology is needed to improve efficiency of care delivery today. New technology and systems must be properly deployed to achieve desired outcomes. The video demonstrates how the ALRT Health-e-Connect System used by trained DCFs facilitates efficiency of care delivery amongst patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals."
To view the DCF/Care Coordination Video Presentation, click here: http://youtu.be/XTizf3hT9g4
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their HEDIS goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.